Patents/Assignees

Ascendis Pharma Endocrinology Division A/S

5 patents in portfolio

US12303553utility2025
Long-acting Growth Hormone Dosage Forms with Superior Efficacy to Daily Somatropin
0 cites
US12274737utility2025
Pegylated Recombinant Human Growth Hormone Compounds
0 cites
US12226457utility2025
Dry Growth Hormone Composition Transiently Linked to a Polymer Carrier
0 cites
US12133883utility2024
Polymeric Hgh Prodrugs
0 cites
US12016903utility2024
Long-acting Growth Hormone Treatment
0 cites